img

Global Dolutegravir Sodium Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dolutegravir Sodium Market Insights, Forecast to 2034

The global Dolutegravir Sodium market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dolutegravir Sodium is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Dolutegravir Sodium is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Dolutegravir Sodium is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Dolutegravir Sodium include ViiV Healthcare UK, Emcure Pharmaceuticals, Aurobindo Pharma, LAURUS Labs, Mylan, Adcock Ingram Limited, Ranbaxy Pharmaceuticals and Cipla, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Dolutegravir Sodium, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Dolutegravir Sodium, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dolutegravir Sodium, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dolutegravir Sodium sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Dolutegravir Sodium market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Dolutegravir Sodium sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ViiV Healthcare UK, Emcure Pharmaceuticals, Aurobindo Pharma, LAURUS Labs, Mylan, Adcock Ingram Limited, Ranbaxy Pharmaceuticals and Cipla, etc.



By Company


ViiV Healthcare UK
Emcure Pharmaceuticals
Aurobindo Pharma
LAURUS Labs
Mylan
Adcock Ingram Limited
Ranbaxy Pharmaceuticals
Cipla
Segment by Type
Bottled Packaging
Film Coated Packaging

Segment by Application


AIDS Adult Patients
AIDS Children over 12 Years Old

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Dolutegravir Sodium in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Dolutegravir Sodium manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dolutegravir Sodium sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Dolutegravir Sodium Product Introduction
1.2 Market by Type
1.2.1 Global Dolutegravir Sodium Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Bottled Packaging
1.2.3 Film Coated Packaging
1.3 Market by Application
1.3.1 Global Dolutegravir Sodium Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 AIDS Adult Patients
1.3.3 AIDS Children over 12 Years Old
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dolutegravir Sodium Sales Estimates and Forecasts 2018-2034
2.2 Global Dolutegravir Sodium Revenue by Region
2.2.1 Global Dolutegravir Sodium Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Dolutegravir Sodium Revenue by Region (2018-2024)
2.2.3 Global Dolutegravir Sodium Revenue by Region (2024-2034)
2.2.4 Global Dolutegravir Sodium Revenue Market Share by Region (2018-2034)
2.3 Global Dolutegravir Sodium Sales Estimates and Forecasts 2018-2034
2.4 Global Dolutegravir Sodium Sales by Region
2.4.1 Global Dolutegravir Sodium Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Dolutegravir Sodium Sales by Region (2018-2024)
2.4.3 Global Dolutegravir Sodium Sales by Region (2024-2034)
2.4.4 Global Dolutegravir Sodium Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dolutegravir Sodium Sales by Manufacturers
3.1.1 Global Dolutegravir Sodium Sales by Manufacturers (2018-2024)
3.1.2 Global Dolutegravir Sodium Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dolutegravir Sodium in 2022
3.2 Global Dolutegravir Sodium Revenue by Manufacturers
3.2.1 Global Dolutegravir Sodium Revenue by Manufacturers (2018-2024)
3.2.2 Global Dolutegravir Sodium Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dolutegravir Sodium Revenue in 2022
3.3 Global Key Players of Dolutegravir Sodium, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Dolutegravir Sodium Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dolutegravir Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dolutegravir Sodium, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dolutegravir Sodium, Product Offered and Application
3.8 Global Key Manufacturers of Dolutegravir Sodium, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dolutegravir Sodium Sales by Type
4.1.1 Global Dolutegravir Sodium Historical Sales by Type (2018-2024)
4.1.2 Global Dolutegravir Sodium Forecasted Sales by Type (2024-2034)
4.1.3 Global Dolutegravir Sodium Sales Market Share by Type (2018-2034)
4.2 Global Dolutegravir Sodium Revenue by Type
4.2.1 Global Dolutegravir Sodium Historical Revenue by Type (2018-2024)
4.2.2 Global Dolutegravir Sodium Forecasted Revenue by Type (2024-2034)
4.2.3 Global Dolutegravir Sodium Revenue Market Share by Type (2018-2034)
4.3 Global Dolutegravir Sodium Price by Type
4.3.1 Global Dolutegravir Sodium Price by Type (2018-2024)
4.3.2 Global Dolutegravir Sodium Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Dolutegravir Sodium Sales by Application
5.1.1 Global Dolutegravir Sodium Historical Sales by Application (2018-2024)
5.1.2 Global Dolutegravir Sodium Forecasted Sales by Application (2024-2034)
5.1.3 Global Dolutegravir Sodium Sales Market Share by Application (2018-2034)
5.2 Global Dolutegravir Sodium Revenue by Application
5.2.1 Global Dolutegravir Sodium Historical Revenue by Application (2018-2024)
5.2.2 Global Dolutegravir Sodium Forecasted Revenue by Application (2024-2034)
5.2.3 Global Dolutegravir Sodium Revenue Market Share by Application (2018-2034)
5.3 Global Dolutegravir Sodium Price by Application
5.3.1 Global Dolutegravir Sodium Price by Application (2018-2024)
5.3.2 Global Dolutegravir Sodium Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Dolutegravir Sodium Market Size by Type
6.1.1 US & Canada Dolutegravir Sodium Sales by Type (2018-2034)
6.1.2 US & Canada Dolutegravir Sodium Revenue by Type (2018-2034)
6.2 US & Canada Dolutegravir Sodium Market Size by Application
6.2.1 US & Canada Dolutegravir Sodium Sales by Application (2018-2034)
6.2.2 US & Canada Dolutegravir Sodium Revenue by Application (2018-2034)
6.3 US & Canada Dolutegravir Sodium Market Size by Country
6.3.1 US & Canada Dolutegravir Sodium Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Dolutegravir Sodium Sales by Country (2018-2034)
6.3.3 US & Canada Dolutegravir Sodium Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dolutegravir Sodium Market Size by Type
7.1.1 Europe Dolutegravir Sodium Sales by Type (2018-2034)
7.1.2 Europe Dolutegravir Sodium Revenue by Type (2018-2034)
7.2 Europe Dolutegravir Sodium Market Size by Application
7.2.1 Europe Dolutegravir Sodium Sales by Application (2018-2034)
7.2.2 Europe Dolutegravir Sodium Revenue by Application (2018-2034)
7.3 Europe Dolutegravir Sodium Market Size by Country
7.3.1 Europe Dolutegravir Sodium Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Dolutegravir Sodium Sales by Country (2018-2034)
7.3.3 Europe Dolutegravir Sodium Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dolutegravir Sodium Market Size
8.1.1 China Dolutegravir Sodium Sales (2018-2034)
8.1.2 China Dolutegravir Sodium Revenue (2018-2034)
8.2 China Dolutegravir Sodium Market Size by Application
8.2.1 China Dolutegravir Sodium Sales by Application (2018-2034)
8.2.2 China Dolutegravir Sodium Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Dolutegravir Sodium Market Size by Type
9.1.1 Asia Dolutegravir Sodium Sales by Type (2018-2034)
9.1.2 Asia Dolutegravir Sodium Revenue by Type (2018-2034)
9.2 Asia Dolutegravir Sodium Market Size by Application
9.2.1 Asia Dolutegravir Sodium Sales by Application (2018-2034)
9.2.2 Asia Dolutegravir Sodium Revenue by Application (2018-2034)
9.3 Asia Dolutegravir Sodium Sales by Region
9.3.1 Asia Dolutegravir Sodium Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Dolutegravir Sodium Revenue by Region (2018-2034)
9.3.3 Asia Dolutegravir Sodium Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dolutegravir Sodium Market Size by Type
10.1.1 Middle East, Africa and Latin America Dolutegravir Sodium Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Dolutegravir Sodium Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Dolutegravir Sodium Market Size by Application
10.2.1 Middle East, Africa and Latin America Dolutegravir Sodium Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Dolutegravir Sodium Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Dolutegravir Sodium Sales by Country
10.3.1 Middle East, Africa and Latin America Dolutegravir Sodium Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Dolutegravir Sodium Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Dolutegravir Sodium Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 ViiV Healthcare UK
11.1.1 ViiV Healthcare UK Company Information
11.1.2 ViiV Healthcare UK Overview
11.1.3 ViiV Healthcare UK Dolutegravir Sodium Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 ViiV Healthcare UK Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ViiV Healthcare UK Recent Developments
11.2 Emcure Pharmaceuticals
11.2.1 Emcure Pharmaceuticals Company Information
11.2.2 Emcure Pharmaceuticals Overview
11.2.3 Emcure Pharmaceuticals Dolutegravir Sodium Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Emcure Pharmaceuticals Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Emcure Pharmaceuticals Recent Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Information
11.3.2 Aurobindo Pharma Overview
11.3.3 Aurobindo Pharma Dolutegravir Sodium Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Aurobindo Pharma Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Aurobindo Pharma Recent Developments
11.4 LAURUS Labs
11.4.1 LAURUS Labs Company Information
11.4.2 LAURUS Labs Overview
11.4.3 LAURUS Labs Dolutegravir Sodium Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 LAURUS Labs Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LAURUS Labs Recent Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Overview
11.5.3 Mylan Dolutegravir Sodium Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Mylan Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Recent Developments
11.6 Adcock Ingram Limited
11.6.1 Adcock Ingram Limited Company Information
11.6.2 Adcock Ingram Limited Overview
11.6.3 Adcock Ingram Limited Dolutegravir Sodium Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Adcock Ingram Limited Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Adcock Ingram Limited Recent Developments
11.7 Ranbaxy Pharmaceuticals
11.7.1 Ranbaxy Pharmaceuticals Company Information
11.7.2 Ranbaxy Pharmaceuticals Overview
11.7.3 Ranbaxy Pharmaceuticals Dolutegravir Sodium Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Ranbaxy Pharmaceuticals Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ranbaxy Pharmaceuticals Recent Developments
11.8 Cipla
11.8.1 Cipla Company Information
11.8.2 Cipla Overview
11.8.3 Cipla Dolutegravir Sodium Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Cipla Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cipla Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dolutegravir Sodium Industry Chain Analysis
12.2 Dolutegravir Sodium Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dolutegravir Sodium Production Mode & Process
12.4 Dolutegravir Sodium Sales and Marketing
12.4.1 Dolutegravir Sodium Sales Channels
12.4.2 Dolutegravir Sodium Distributors
12.5 Dolutegravir Sodium Customers
13 Market Dynamics
13.1 Dolutegravir Sodium Industry Trends
13.2 Dolutegravir Sodium Market Drivers
13.3 Dolutegravir Sodium Market Challenges
13.4 Dolutegravir Sodium Market Restraints
14 Key Findings in The Global Dolutegravir Sodium Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Dolutegravir Sodium Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Bottled Packaging
Table 3. Major Manufacturers of Film Coated Packaging
Table 4. Global Dolutegravir Sodium Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Dolutegravir Sodium Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Dolutegravir Sodium Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Dolutegravir Sodium Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Dolutegravir Sodium Revenue Market Share by Region (2018-2024)
Table 9. Global Dolutegravir Sodium Revenue Market Share by Region (2024-2034)
Table 10. Global Dolutegravir Sodium Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Dolutegravir Sodium Sales by Region (2018-2024) & (K Pcs)
Table 12. Global Dolutegravir Sodium Sales by Region (2024-2034) & (K Pcs)
Table 13. Global Dolutegravir Sodium Sales Market Share by Region (2018-2024)
Table 14. Global Dolutegravir Sodium Sales Market Share by Region (2024-2034)
Table 15. Global Dolutegravir Sodium Sales by Manufacturers (2018-2024) & (K Pcs)
Table 16. Global Dolutegravir Sodium Sales Share by Manufacturers (2018-2024)
Table 17. Global Dolutegravir Sodium Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Dolutegravir Sodium Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Dolutegravir Sodium, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Dolutegravir Sodium Price by Manufacturers 2018-2024 (USD/Pcs)
Table 21. Global Dolutegravir Sodium Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Dolutegravir Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dolutegravir Sodium as of 2022)
Table 23. Global Key Manufacturers of Dolutegravir Sodium, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Dolutegravir Sodium, Product Offered and Application
Table 25. Global Key Manufacturers of Dolutegravir Sodium, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dolutegravir Sodium Sales by Type (2018-2024) & (K Pcs)
Table 28. Global Dolutegravir Sodium Sales by Type (2024-2034) & (K Pcs)
Table 29. Global Dolutegravir Sodium Sales Share by Type (2018-2024)
Table 30. Global Dolutegravir Sodium Sales Share by Type (2024-2034)
Table 31. Global Dolutegravir Sodium Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Dolutegravir Sodium Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Dolutegravir Sodium Revenue Share by Type (2018-2024)
Table 34. Global Dolutegravir Sodium Revenue Share by Type (2024-2034)
Table 35. Dolutegravir Sodium Price by Type (2018-2024) & (USD/Pcs)
Table 36. Global Dolutegravir Sodium Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 37. Global Dolutegravir Sodium Sales by Application (2018-2024) & (K Pcs)
Table 38. Global Dolutegravir Sodium Sales by Application (2024-2034) & (K Pcs)
Table 39. Global Dolutegravir Sodium Sales Share by Application (2018-2024)
Table 40. Global Dolutegravir Sodium Sales Share by Application (2024-2034)
Table 41. Global Dolutegravir Sodium Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Dolutegravir Sodium Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Dolutegravir Sodium Revenue Share by Application (2018-2024)
Table 44. Global Dolutegravir Sodium Revenue Share by Application (2024-2034)
Table 45. Dolutegravir Sodium Price by Application (2018-2024) & (USD/Pcs)
Table 46. Global Dolutegravir Sodium Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 47. US & Canada Dolutegravir Sodium Sales by Type (2018-2024) & (K Pcs)
Table 48. US & Canada Dolutegravir Sodium Sales by Type (2024-2034) & (K Pcs)
Table 49. US & Canada Dolutegravir Sodium Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Dolutegravir Sodium Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Dolutegravir Sodium Sales by Application (2018-2024) & (K Pcs)
Table 52. US & Canada Dolutegravir Sodium Sales by Application (2024-2034) & (K Pcs)
Table 53. US & Canada Dolutegravir Sodium Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Dolutegravir Sodium Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Dolutegravir Sodium Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 56. US & Canada Dolutegravir Sodium Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Dolutegravir Sodium Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Dolutegravir Sodium Sales by Country (2018-2024) & (K Pcs)
Table 59. US & Canada Dolutegravir Sodium Sales by Country (2024-2034) & (K Pcs)
Table 60. Europe Dolutegravir Sodium Sales by Type (2018-2024) & (K Pcs)
Table 61. Europe Dolutegravir Sodium Sales by Type (2024-2034) & (K Pcs)
Table 62. Europe Dolutegravir Sodium Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Dolutegravir Sodium Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Dolutegravir Sodium Sales by Application (2018-2024) & (K Pcs)
Table 65. Europe Dolutegravir Sodium Sales by Application (2024-2034) & (K Pcs)
Table 66. Europe Dolutegravir Sodium Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Dolutegravir Sodium Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Dolutegravir Sodium Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 69. Europe Dolutegravir Sodium Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Dolutegravir Sodium Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Dolutegravir Sodium Sales by Country (2018-2024) & (K Pcs)
Table 72. Europe Dolutegravir Sodium Sales by Country (2024-2034) & (K Pcs)
Table 73. China Dolutegravir Sodium Sales by Type (2018-2024) & (K Pcs)
Table 74. China Dolutegravir Sodium Sales by Type (2024-2034) & (K Pcs)
Table 75. China Dolutegravir Sodium Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Dolutegravir Sodium Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Dolutegravir Sodium Sales by Application (2018-2024) & (K Pcs)
Table 78. China Dolutegravir Sodium Sales by Application (2024-2034) & (K Pcs)
Table 79. China Dolutegravir Sodium Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Dolutegravir Sodium Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Dolutegravir Sodium Sales by Type (2018-2024) & (K Pcs)
Table 82. Asia Dolutegravir Sodium Sales by Type (2024-2034) & (K Pcs)
Table 83. Asia Dolutegravir Sodium Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Dolutegravir Sodium Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Dolutegravir Sodium Sales by Application (2018-2024) & (K Pcs)
Table 86. Asia Dolutegravir Sodium Sales by Application (2024-2034) & (K Pcs)
Table 87. Asia Dolutegravir Sodium Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Dolutegravir Sodium Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Dolutegravir Sodium Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 90. Asia Dolutegravir Sodium Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Dolutegravir Sodium Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Dolutegravir Sodium Sales by Region (2018-2024) & (K Pcs)
Table 93. Asia Dolutegravir Sodium Sales by Region (2024-2034) & (K Pcs)
Table 94. Middle East, Africa and Latin America Dolutegravir Sodium Sales by Type (2018-2024) & (K Pcs)
Table 95. Middle East, Africa and Latin America Dolutegravir Sodium Sales by Type (2024-2034) & (K Pcs)
Table 96. Middle East, Africa and Latin America Dolutegravir Sodium Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Dolutegravir Sodium Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Dolutegravir Sodium Sales by Application (2018-2024) & (K Pcs)
Table 99. Middle East, Africa and Latin America Dolutegravir Sodium Sales by Application (2024-2034) & (K Pcs)
Table 100. Middle East, Africa and Latin America Dolutegravir Sodium Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Dolutegravir Sodium Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Dolutegravir Sodium Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Dolutegravir Sodium Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Dolutegravir Sodium Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Dolutegravir Sodium Sales by Country (2018-2024) & (K Pcs)
Table 106. Middle East, Africa and Latin America Dolutegravir Sodium Sales by Country (2024-2034) & (K Pcs)
Table 107. ViiV Healthcare UK Company Information
Table 108. ViiV Healthcare UK Description and Major Businesses
Table 109. ViiV Healthcare UK Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. ViiV Healthcare UK Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. ViiV Healthcare UK Recent Developments
Table 112. Emcure Pharmaceuticals Company Information
Table 113. Emcure Pharmaceuticals Description and Major Businesses
Table 114. Emcure Pharmaceuticals Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. Emcure Pharmaceuticals Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Emcure Pharmaceuticals Recent Developments
Table 117. Aurobindo Pharma Company Information
Table 118. Aurobindo Pharma Description and Major Businesses
Table 119. Aurobindo Pharma Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. Aurobindo Pharma Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Aurobindo Pharma Recent Developments
Table 122. LAURUS Labs Company Information
Table 123. LAURUS Labs Description and Major Businesses
Table 124. LAURUS Labs Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. LAURUS Labs Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. LAURUS Labs Recent Developments
Table 127. Mylan Company Information
Table 128. Mylan Description and Major Businesses
Table 129. Mylan Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Mylan Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Mylan Recent Developments
Table 132. Adcock Ingram Limited Company Information
Table 133. Adcock Ingram Limited Description and Major Businesses
Table 134. Adcock Ingram Limited Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. Adcock Ingram Limited Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Adcock Ingram Limited Recent Developments
Table 137. Ranbaxy Pharmaceuticals Company Information
Table 138. Ranbaxy Pharmaceuticals Description and Major Businesses
Table 139. Ranbaxy Pharmaceuticals Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. Ranbaxy Pharmaceuticals Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Ranbaxy Pharmaceuticals Recent Developments
Table 142. Cipla Company Information
Table 143. Cipla Description and Major Businesses
Table 144. Cipla Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. Cipla Dolutegravir Sodium Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Cipla Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Dolutegravir Sodium Distributors List
Table 150. Dolutegravir Sodium Customers List
Table 151. Dolutegravir Sodium Market Trends
Table 152. Dolutegravir Sodium Market Drivers
Table 153. Dolutegravir Sodium Market Challenges
Table 154. Dolutegravir Sodium Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Dolutegravir Sodium Product Picture
Figure 2. Global Dolutegravir Sodium Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Dolutegravir Sodium Market Share by Type in 2022 & 2034
Figure 4. Bottled Packaging Product Picture
Figure 5. Film Coated Packaging Product Picture
Figure 6. Global Dolutegravir Sodium Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Dolutegravir Sodium Market Share by Application in 2022 & 2034
Figure 8. AIDS Adult Patients
Figure 9. AIDS Children over 12 Years Old
Figure 10. Dolutegravir Sodium Report Years Considered
Figure 11. Global Dolutegravir Sodium Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Dolutegravir Sodium Revenue 2018-2034 (US$ Million)
Figure 13. Global Dolutegravir Sodium Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global Dolutegravir Sodium Revenue Market Share by Region (2018-2034)
Figure 15. Global Dolutegravir Sodium Sales 2018-2034 ((K Pcs)
Figure 16. Global Dolutegravir Sodium Sales Market Share by Region (2018-2034)
Figure 17. US & Canada Dolutegravir Sodium Sales YoY (2018-2034) & (K Pcs)
Figure 18. US & Canada Dolutegravir Sodium Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Dolutegravir Sodium Sales YoY (2018-2034) & (K Pcs)
Figure 20. Europe Dolutegravir Sodium Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Dolutegravir Sodium Sales YoY (2018-2034) & (K Pcs)
Figure 22. China Dolutegravir Sodium Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Asia (excluding China) Dolutegravir Sodium Sales YoY (2018-2034) & (K Pcs)
Figure 24. Asia (excluding China) Dolutegravir Sodium Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Dolutegravir Sodium Sales YoY (2018-2034) & (K Pcs)
Figure 26. Middle East, Africa and Latin America Dolutegravir Sodium Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Dolutegravir Sodium Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Dolutegravir Sodium in the World: Market Share by Dolutegravir Sodium Revenue in 2022
Figure 29. Global Dolutegravir Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Dolutegravir Sodium Sales Market Share by Type (2018-2034)
Figure 31. Global Dolutegravir Sodium Revenue Market Share by Type (2018-2034)
Figure 32. Global Dolutegravir Sodium Sales Market Share by Application (2018-2034)
Figure 33. Global Dolutegravir Sodium Revenue Market Share by Application (2018-2034)
Figure 34. US & Canada Dolutegravir Sodium Sales Market Share by Type (2018-2034)
Figure 35. US & Canada Dolutegravir Sodium Revenue Market Share by Type (2018-2034)
Figure 36. US & Canada Dolutegravir Sodium Sales Market Share by Application (2018-2034)
Figure 37. US & Canada Dolutegravir Sodium Revenue Market Share by Application (2018-2034)
Figure 38. US & Canada Dolutegravir Sodium Revenue Share by Country (2018-2034)
Figure 39. US & Canada Dolutegravir Sodium Sales Share by Country (2018-2034)
Figure 40. U.S. Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 41. Canada Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 42. Europe Dolutegravir Sodium Sales Market Share by Type (2018-2034)
Figure 43. Europe Dolutegravir Sodium Revenue Market Share by Type (2018-2034)
Figure 44. Europe Dolutegravir Sodium Sales Market Share by Application (2018-2034)
Figure 45. Europe Dolutegravir Sodium Revenue Market Share by Application (2018-2034)
Figure 46. Europe Dolutegravir Sodium Revenue Share by Country (2018-2034)
Figure 47. Europe Dolutegravir Sodium Sales Share by Country (2018-2034)
Figure 48. Germany Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 49. France Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 50. U.K. Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 51. Italy Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 52. Russia Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 53. China Dolutegravir Sodium Sales Market Share by Type (2018-2034)
Figure 54. China Dolutegravir Sodium Revenue Market Share by Type (2018-2034)
Figure 55. China Dolutegravir Sodium Sales Market Share by Application (2018-2034)
Figure 56. China Dolutegravir Sodium Revenue Market Share by Application (2018-2034)
Figure 57. Asia Dolutegravir Sodium Sales Market Share by Type (2018-2034)
Figure 58. Asia Dolutegravir Sodium Revenue Market Share by Type (2018-2034)
Figure 59. Asia Dolutegravir Sodium Sales Market Share by Application (2018-2034)
Figure 60. Asia Dolutegravir Sodium Revenue Market Share by Application (2018-2034)
Figure 61. Asia Dolutegravir Sodium Revenue Share by Region (2018-2034)
Figure 62. Asia Dolutegravir Sodium Sales Share by Region (2018-2034)
Figure 63. Japan Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 64. South Korea Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 65. China Taiwan Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 66. Southeast Asia Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 67. India Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Dolutegravir Sodium Sales Market Share by Type (2018-2034)
Figure 69. Middle East, Africa and Latin America Dolutegravir Sodium Revenue Market Share by Type (2018-2034)
Figure 70. Middle East, Africa and Latin America Dolutegravir Sodium Sales Market Share by Application (2018-2034)
Figure 71. Middle East, Africa and Latin America Dolutegravir Sodium Revenue Market Share by Application (2018-2034)
Figure 72. Middle East, Africa and Latin America Dolutegravir Sodium Revenue Share by Country (2018-2034)
Figure 73. Middle East, Africa and Latin America Dolutegravir Sodium Sales Share by Country (2018-2034)
Figure 74. Brazil Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 75. Mexico Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 76. Turkey Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 77. Israel Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 78. GCC Countries Dolutegravir Sodium Revenue (2018-2034) & (US$ Million)
Figure 79. Dolutegravir Sodium Value Chain
Figure 80. Dolutegravir Sodium Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed